Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

10/11/2017 06:00

Nov 10 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               3.63                2.98             8.70      
                   (+22.0 pct)         (-8.0 pct)       (+4.9 pct)   
  Operating          502 mln             474 mln           1.55      
                   (+6.0 pct)          (+19.2 pct)      (+0.4 pct)   
  Recurring          382 mln             318 mln           1.30      
                   (+20.1 pct)         (-21.3 pct)      (-7.6 pct)   
  Net                276 mln             254 mln          900 mln    
                   (+8.5 pct)         (+106.2 pct)      (-14.2 pct)  
  EPS               19.54 yen           18.91 yen        63.74 yen   
  EPS Diluted       19.47 yen           18.73 yen                    
  Ann Div                               20.00 yen        15.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               20.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T  
  ((Tokyo Headline News Desk +813 6441 1812))